NCT04037865 - A Renal Impairment Study for PF-06651600 | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 19, 2019

Primary Completion Date

March 31, 2020

Study Completion Date

March 31, 2020

Conditions

Renal Impairment

Interventions

DRUG

PF-06651600

PF-06651600 50 mg oral tablets will be administered on Days 1 to 10

Trial Locations (3)

Investigational Drug Services (IDS) University of Miami Hospitals and Clinics, Miami

University of Miami Division of Clinical Pharmacology, Miami

Prism Clinical Research, LLC, Saint Paul